Propofol and Adalat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Propofol (propofol) and Adalat (nifedipine). Common drug interactions include abdominal pain upper among females and hypokalaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Propofol and Adalat. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Propofol?

Propofol has active ingredients of propofol. It is often used in colonoscopy abnormal. eHealthMe is studying from 38,224 Propofol users. Check the latest studies of Propofol.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

On Jul, 16, 2026

63 people who take Propofol and Adalat together, and have interactions are studied.

What are the common drug interactions of Propofol and Adalat, by gender? *:

female:

Abdominal pain upper
Acute respiratory failure
Anaemia (lack of blood)
Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood pressure decreased
Cardiac arrest
Cardiac failure congestive
Cardiac valve disease (heart valve disease)
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)

male:

Hypokalaemia (low potassium)
Liver carcinoma ruptured (ruptured liver cancer tumour)
Drug eruption (adverse drug reaction of the skin)
Hepatitis b
Anaphylactic reaction (serious allergic reaction)
Hepatocellular damage (liver damage)
Hepatomegaly (abnormal enlargement of the liver)
Hyperkalaemia (damage to or disease of the kidney)
Kidney transplant rejection
Loss of consciousness

What are the common drug interactions of Propofol and Adalat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrioventricular block complete (heart block complete)
Blood triglycerides increased
Bradycardia (abnormally slow heart action)
Cardiac arrest
Cardiogenic shock (inadequate circulation of blood)
Electrocardiogram qt prolonged
Hepatic steatosis (fatty liver disease)
Hepatitis (inflammation of the liver)
Hepatocellular damage (liver damage)

40-49:

Hypokalaemia (low potassium)
Liver carcinoma ruptured (ruptured liver cancer tumour)
Aspartate aminotransferase increased
Abdominal pain
Diarrhoea
Hepatic failure (liver failure)
Kidney transplant rejection
Loss of consciousness
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Anaphylactic reaction (serious allergic reaction)

50-59:

Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Nausea (feeling of having an urge to vomit)
Organ failure
Pancreatitis (inflammation of pancreas)
Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
Pneumonia
Pyrexia (fever)
Renal failure acute (rapid kidney dysfunction)
Sepsis (a severe blood infection that can lead to organ failure and death)
Septic shock (shock due to blood infection)

60+:

Oxygen saturation decreased
Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Fear
Injury
Renal failure (kidney dysfunction)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Death
Emotional distress
Multi-organ failure (multisystem organ failure)
Renal impairment (severely reduced kidney function)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 11 people, 17.46%
Pain: 10 people, 15.87%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 9 people, 14.29%
Oesophagitis (inflammation of oesophagus): 9 people, 14.29%
Headache (pain in head): 9 people, 14.29%
Hepatic Neoplasm Malignant (liver cancer): 9 people, 14.29%
Hepatitis B: 9 people, 14.29%
Abdominal Pain: 9 people, 14.29%
Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 9 people, 14.29%
Weakness: 8 people, 12.70%

* Approximation only. Some reports may have incomplete information.

Do you take Propofol and Adalat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously